Systems pharmacology to predict drug toxicity: Integration across levels of biological organization

Jane P F Bai, Darrell R. Abernethy

Research output: Contribution to journalArticle

Abstract

To achieve sensitive and specific mechanism-based prediction of drug toxicity, the tools of systems pharmacology will be integrated using structured ontological approaches, analytics, mathematics, and statistics. Success of this effort is based on the assumption that a systems network that consists of drug-induced perturbations of physiological functions can be characterized. This network spans the hierarchy of biological organization, from gene to mRNA to protein to intracellular organelle to cell to organ to organism. It is populated with data from each of these levels of biological organization. These data, from disparate sources, include the published literature, drug development archives of all approved drugs and drug candidates that did not complete development, and various toxicity databases and adverse event reporting systems. The network contains interrelated genomics, transcriptomics, and metabolomics data, as well as organ and physiological functional data that are derived from the universe of information that describes and analyzes drug toxicity. Here we describe advances in bioinformatics, computer sciences, next-generation sequencing, and systems biology that create the opportunity for integrated systems pharmacology-based prediction of drug safety.

Original languageEnglish (US)
Pages (from-to)451-473
Number of pages23
JournalAnnual Review of Pharmacology and Toxicology
Volume53
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Toxicity
Pharmacology
Pharmaceutical Preparations
Metabolomics
Systems Biology
Mathematics
Information Storage and Retrieval
Genomics
Computational Biology
Organelles
Bioinformatics
Databases
Computer science
Safety
Messenger RNA
Genes
Statistics
Proteins

Keywords

  • adverse drug effects
  • bioinformatics
  • systems analysis

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Systems pharmacology to predict drug toxicity : Integration across levels of biological organization. / Bai, Jane P F; Abernethy, Darrell R.

In: Annual Review of Pharmacology and Toxicology, Vol. 53, 01.2013, p. 451-473.

Research output: Contribution to journalArticle

@article{4e6e8538adfb4d4a94caf64d100a6a78,
title = "Systems pharmacology to predict drug toxicity: Integration across levels of biological organization",
abstract = "To achieve sensitive and specific mechanism-based prediction of drug toxicity, the tools of systems pharmacology will be integrated using structured ontological approaches, analytics, mathematics, and statistics. Success of this effort is based on the assumption that a systems network that consists of drug-induced perturbations of physiological functions can be characterized. This network spans the hierarchy of biological organization, from gene to mRNA to protein to intracellular organelle to cell to organ to organism. It is populated with data from each of these levels of biological organization. These data, from disparate sources, include the published literature, drug development archives of all approved drugs and drug candidates that did not complete development, and various toxicity databases and adverse event reporting systems. The network contains interrelated genomics, transcriptomics, and metabolomics data, as well as organ and physiological functional data that are derived from the universe of information that describes and analyzes drug toxicity. Here we describe advances in bioinformatics, computer sciences, next-generation sequencing, and systems biology that create the opportunity for integrated systems pharmacology-based prediction of drug safety.",
keywords = "adverse drug effects, bioinformatics, systems analysis",
author = "Bai, {Jane P F} and Abernethy, {Darrell R.}",
year = "2013",
month = "1",
doi = "10.1146/annurev-pharmtox-011112-140248",
language = "English (US)",
volume = "53",
pages = "451--473",
journal = "Annual Review of Pharmacology and Toxicology",
issn = "0362-1642",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Systems pharmacology to predict drug toxicity

T2 - Integration across levels of biological organization

AU - Bai, Jane P F

AU - Abernethy, Darrell R.

PY - 2013/1

Y1 - 2013/1

N2 - To achieve sensitive and specific mechanism-based prediction of drug toxicity, the tools of systems pharmacology will be integrated using structured ontological approaches, analytics, mathematics, and statistics. Success of this effort is based on the assumption that a systems network that consists of drug-induced perturbations of physiological functions can be characterized. This network spans the hierarchy of biological organization, from gene to mRNA to protein to intracellular organelle to cell to organ to organism. It is populated with data from each of these levels of biological organization. These data, from disparate sources, include the published literature, drug development archives of all approved drugs and drug candidates that did not complete development, and various toxicity databases and adverse event reporting systems. The network contains interrelated genomics, transcriptomics, and metabolomics data, as well as organ and physiological functional data that are derived from the universe of information that describes and analyzes drug toxicity. Here we describe advances in bioinformatics, computer sciences, next-generation sequencing, and systems biology that create the opportunity for integrated systems pharmacology-based prediction of drug safety.

AB - To achieve sensitive and specific mechanism-based prediction of drug toxicity, the tools of systems pharmacology will be integrated using structured ontological approaches, analytics, mathematics, and statistics. Success of this effort is based on the assumption that a systems network that consists of drug-induced perturbations of physiological functions can be characterized. This network spans the hierarchy of biological organization, from gene to mRNA to protein to intracellular organelle to cell to organ to organism. It is populated with data from each of these levels of biological organization. These data, from disparate sources, include the published literature, drug development archives of all approved drugs and drug candidates that did not complete development, and various toxicity databases and adverse event reporting systems. The network contains interrelated genomics, transcriptomics, and metabolomics data, as well as organ and physiological functional data that are derived from the universe of information that describes and analyzes drug toxicity. Here we describe advances in bioinformatics, computer sciences, next-generation sequencing, and systems biology that create the opportunity for integrated systems pharmacology-based prediction of drug safety.

KW - adverse drug effects

KW - bioinformatics

KW - systems analysis

UR - http://www.scopus.com/inward/record.url?scp=84872243783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872243783&partnerID=8YFLogxK

U2 - 10.1146/annurev-pharmtox-011112-140248

DO - 10.1146/annurev-pharmtox-011112-140248

M3 - Article

C2 - 23140241

AN - SCOPUS:84872243783

VL - 53

SP - 451

EP - 473

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

SN - 0362-1642

ER -